Tyra BiosciencesvsUnitedHealth

TYRA and UNH stock compared: price, dividend, valuation and results, from SEC filings.

TYRA

Tyra Biosciences, Inc.

$20.12

Value $1.4B

+1.98%
TYRA's page

UNH

UnitedHealth Group Incorporated

$339.85

Value $308B

+2.84%
UNH's page

Tyra Biosciences (TYRA) has a market value of $1.4B and UnitedHealth (UNH) $308B. Over the last year, with dividends, TYRA moved +21.1% and UNH +12.9%. Dividend yield: TYRA none, UNH 2.67%.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    TYRA$1.4B

    UNH$308B

    UNH is 222 times TYRA

  • Revenue, 12 months

    TYRA–

    UNH$450B

  • Net income, 12 months

    TYRA-$170M

    UNH$15.9B

  • Operating margin

    TYRA–

    UNH5.3%

  • ROIC

    TYRA-40.5%

    UNH11.3%

    51.8 points apart

  • P/E

    TYRA–

    UNH19.4

  • Dividend yield

    TYRA0.0%

    UNH2.7%

    2.7 points apart

  • 5-year return

    TYRA-16.2%

    UNH-15.4%

    0.8 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

TYRA-16.2%

UNH-15.4%

5010015020222023202420252026
Returns by period
PeriodTYRAWith dividendsUNHWith dividends
1 year since November 19, 2025+21.1%Price +21.1%+12.9%Price +10.0%
3 years since November 20, 2023+78.5%+21.3% a yearPrice +78.5%-32.4%-12.2% a yearPrice -36.5%
5 years since November 19, 2021-16.2%-3.5% a yearPrice -16.2%-15.4%-3.3% a yearPrice -22.8%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

TYRATyra BiosciencesUNHUnitedHealth

Valuation

TYRAUNH
Valuation
Price$20.12$339.85
Market value$1.4B$308B
Enterprise value (EV)$934M$354B
P/E–19.4
P/E, 5-year median–25.0
P/B2.03.0
EV/EBIT–14.8
Free cash flow yield–7.4%

Results and growth

TYRAUNH
Results and growth
Revenue, 12 months–$450B
Net income, 12 months-$170M$15.9B
Free cash flow, 12 months-$120M$22.8B
Earnings per share, 12 months-$2.63$17.52
Revenue growth, year on year–11.8%
Revenue growth a year, past–+11.7%over 5 years
EPS growth a year, past–-3.8%over 5 years

Margins and returns on capital

TYRAUNH
Margins and returns on capital
Gross margin–88.3%
Operating margin–5.3%
Net margin–3.5%
ROIC-40.5%11.3%
ROE-43.0%15.5%

Balance sheet

TYRAUNH
Balance sheet
Cash$456M$28.5B
Total debt$5.5M$74.3B
Net debt / EBITDA–1.6
Interest cover–6.2×

Dividends and buybacks

TYRAUNH
Dividends and buybacks
Dividend yield–2.7%
Dividend per share, 12 months–$9.06
Dividend growth a year, past–+12.6%over 5 years
Buyback yield–1.8%
Shareholder yield–4.5%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: TYRA or UNH

Didn't find what you were looking for?

Ask us
Which is bigger, Tyra Biosciences or UnitedHealth?

By market value, UnitedHealth ($308B) is about 221.9 times Tyra Biosciences ($1.4B), at today's prices.

How did TYRA and UNH stock do over the last 5 years?

Since November 19, 2021, TYRA's price moved -16.2% and UNH's -22.8%. With dividends: TYRA -16.2% (-3.5% a year), UNH -15.4% (-3.3% a year). Past returns do not predict future ones.

Which pays the higher dividend, TYRA or UNH?

The dividend yield at today's price is none for Tyra Biosciences and 2.67% for UnitedHealth. Over the last twelve months they paid – and $9.06 per share.

Which is the better investment, Tyra Biosciences or UnitedHealth?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.